Subjective Cognitive Decline Among Adults Aged ≥45 Years — United States, 2015–2016
Weekly / July 13, 2018 / 67(27);753–757
Views: Views equals page views plus PDF downloadsMetric Details
Christopher A. Taylor, PhD1; Erin D. Bouldin, PhD1,2; Lisa C. McGuire, PhD1 (View author affiliations)View suggested citation
What is already known about this topic?
Subjective cognitive decline (SCD) is a form of impairment in which more frequent or worsening confusion or memory loss can affect the ability to care for oneself.
What is added by this report?
Among adults aged ≥45 years, 11.2% reported SCD, including 10.4% of adults aged 45–54 years. Among all persons who reported SCD, only 45.4% had discussed it with a health care professional.
What are the implications for public health practice?
Adults with confusion or memory loss should talk to a health care professional who can assess cognitive decline and address possible treatment of symptoms, management of other co-occurring chronic health conditions, advance care planning, and caregiving needs, and who ensures that the patient receives appropriate information and referrals.
Subjective cognitive decline (SCD) is the self-reported experience of worsening or more frequent confusion or memory loss within the previous 12 months (1,2) and one of the earliest noticeable symptoms of Alzheimer’s disease (Alzheimer’s), a fatal form of dementia (i.e., a decline in mental abilities severe enough to interfere with everyday life) (1). Alzheimer’s is the most common form of dementia, although not all memory loss results from Alzheimer’s (3). To examine SCD, CDC analyzed combined data from the 2015 and 2016 Behavioral Risk Factor Surveillance System (BRFSS) surveys. Overall, 11.2% of adults aged ≥45 years reported having SCD, 50.6% of whom reported SCD-related functional limitations. Among persons living alone aged ≥45 years, 13.8% reported SCD; among persons with any chronic disease, 15.2% reported SCD. Adults should discuss confusion or memory loss with a health care professional who can assess cognitive decline and address possible treatments and issues related to chronic disease management, medical care, and caregiving.
BRFSS is a state-based, random-digit–dialed telephone survey of noninstitutionalized adults aged ≥18 years in all 50 states, the District of Columbia (DC), and several U.S. territories.* The six-question cognitive decline module (optional for states in 2015 and 2016) examines how SCD affects the life of respondents aged ≥45 years, including difficulties performing activities or caring for themselves. Overall, 49 states (all except Pennsylvania), Puerto Rico, and DC administered the module in one or both years. For five states that administered the module in both years, only 2016 data were included in this analysis. For the BRFSS surveys in 2015 and 2016, the overall combined landline and cellular telephone response rates among states, Puerto Rico, and DC ranged from 30.7% to 65.0% (median = 47.1%).†
Respondents who answered affirmatively to the question “During the past 12 months, have you experienced confusion or memory loss that is happening more often or is getting worse?” were classified as having SCD. Respondents with SCD were asked if SCD caused them to give up day-to-day activities such as cooking, cleaning, taking medications, driving, or paying bills; how often they needed and could receive necessary assistance with those activities; how often SCD interfered with their ability to work, volunteer, or engage in social activities; and whether they had discussed SCD with a health care professional. Respondents who reported “always,” “usually,” or “sometimes” (as opposed to “rarely” or “never”) giving up day-to-day activities or interference with ability to work, volunteer, or engage in social activities were classified as having SCD-related functional limitations.
Data were examined by age group, sex, race/ethnicity, education level, veteran status, employment, and living alone. Chronic disease status was ascertained by history of heart disease; stroke, or cerebrovascular disease; asthma; lung disease; cancer (other than skin); arthritis; or diabetes. Data were analyzed using statistical software and methods that accounted for the complex survey design and weighted data. Prevalence rates were unadjusted.
Among adults aged ≥45 years, 11.2% reported SCD, 50.6% of whom reported SCD-related functional difficulties (Table 1). SCD prevalence increased with age, from 10.4% among adults aged 45–54 years to 14.3% among those aged ≥75 years and was lower among college graduates (7.0%) than among those with less than high school education (18.2%). The prevalence of SCD-related functional difficulties among college graduates (30.8%) was half that of those without a high school diploma (64.9%). Among persons living alone, 13.8% reported SCD; 55.7% of those reported SCD-related functional difficulties (Table 1).
The prevalence of SCD varied by state (Table 2). The lowest prevalence of SCD was reported in South Dakota (6.0%), and the highest was reported in Nevada (16.3%).
Nearly twice the percentage of persons reporting SCD-related functional limitations had talked to a health care professional (58.1%) compared with those without functional limitations (30.4%) (Table 3). Among persons with a functional difficulty, 81.1% reported having given up household activities or chores because of SCD, and 73.3% reported that SCD interfered with their ability to work, volunteer, or engage in social activities.
SCD can be a symptom of early-stage dementia conditions, including Alzheimer’s (1,2). Not everyone who reports SCD will develop dementia, but some studies have shown that half of older adults with subjective memory complaints go on to develop more severe cognitive decline within 7–18 years (1,4,5). Even without progression to more severe cognitive impairment, SCD might signify a decreased ability for self-care. Inability to perform activities important to daily living such as preparing meals or managing money affect the ability to live independently and might also affect the ability to socialize or remain fully employed.
These findings are similar to those from an analysis of persons aged ≥60 years in 21 states from the 2011 BRFSS survey, which found a 12.7% prevalence of SCD (6). In that study, the highest prevalence was among Hispanics (16.9%) and the lowest was among non-Hispanic blacks (11.8%), in contrast to the current study, which found the highest prevalence among non-Hispanic American Indians and Alaska Natives (19.6%) and the lowest among non-Hispanic Asians or Native Hawaiians/Other Pacific Islanders (6.8%). The inclusion of additional states and the expansion of the age groups might have contributed to these differences.
In both 2011 (6) and 2015–2016, a higher SCD prevalence was found among adults aged ≥75 years than among those aged 45–74 years. This is similar to the prevalence of Alzheimer’s, according to 2018 data from the Alzheimer’s Association, which found an estimated 3% of persons aged 65–74 years, 17% of persons aged 75–84 years, and 32% of persons aged ≥85 years had Alzheimer’s (1,7). This analysis found a higher prevalence of SCD and related functional limitations in persons with less formal education, similar to previously reported patterns of higher dementia prevalence in persons with less formal education (8).
Younger adults might be more likely to attribute limitations in their lifestyle to SCD or might be more sensitive to its effects. Conversely, older adults might be less aware of the effects of SCD or consider it a normal part of aging. Among persons aged 45–54 years, 10.4% reported SCD, and 59.8% of those persons reported SCD-related limitations that affected work, household chores, or social activities. Although Alzheimer’s is rare in persons aged <65 years, the finding of SCD and related functional limitations among younger adults could indicate early symptoms of cognitive decline that can be a precursor to memory disorders and dementia like Alzheimer’s. These functional limitations might have important health and economic impacts. Adults aged 45–54 years are in their prime working years, when salaries peak, workers are most productive, and when workers contribute to their retirements and consume goods and services (9). An inability to work during these years might have financial implications for these adults and their families. Persons with SCD-related functional limitations might have to reduce their time working or leave the workforce entirely; in this study, nearly three fourths of those with a functional difficulty reported that SCD interfered with their ability to engage in activities outside the home, including working.
Fewer than half (45.4%) of respondents with SCD reported speaking to a health care professional about it. More than half of those with SCD-related functional limitations reported speaking to a health care professional about SCD compared with fewer than one third of persons without such limitations, suggesting that limitations in ability to perform instrumental activities of daily living might prompt discussion with a health care professional. Persons might incorrectly believe that cognitive decline is an inevitable part of aging, which could discourage them from consulting a health care professional. CDC encourages persons with confusion or memory loss to talk to a health care professional. After evaluation, even if treatment of symptoms is not an option, early assessment of cognitive issues can facilitate addressing potential safety issues, discussion of advanced care planning, including the need for caregiving, and ensuring receipt of appropriate information and referrals (10). Early assessment is important because memory issues can affect a person’s ability to manage their health; among those reporting other chronic health conditions, 15.2% also had SCD.
The findings in this report are subject to at least three limitations. First, data on SCD are self-reported. Whereas the SCD module was cognitively tested, it is not administered alongside an objective measure of cognitive performance. Therefore, the accuracy of the reports of SCD is unknown. Second, response bias might affect response to SCD questions and might underestimate SCD prevalence. Finally, BRFSS is not administered to persons with known cognitive problems who might not generate reliable data. In addition, BRFSS is only administered to noninstitutionalized adults, excluding adults living in long-term care facilities, where a proportion of residents have SCD. Therefore, these results cannot be used to estimate the prevalence of SCD across all U.S. populations.
Cognitive decline is an important public health issue affecting older adults, their families, and their caregivers, as well as the economy and health care system. As a precursor to dementia, including Alzheimer’s, SCD can impair a person’s ability to care for themselves by limiting their ability to work, particularly those adults who report SCD in their prime working years (i.e., 45–54 years). Estimating the prevalence of SCD might allow states to plan for those who might develop dementia in the future.
Conflict of Interest
No conflicts of interest were reported.
Corresponding author: Christopher A. Taylor, email@example.com, 770-488-1121.
1Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, CDC; 2Department of Health and Exercise Science, Beaver College of Health Sciences, Appalachian State University, Boone, North Carolina.
- Alzheimer’s Association. 2018 Alzheimer’s disease facts and figures. Alzheimers Dement 2018;14:367–429. CrossRef
- Reid LM, Maclullich AM. Subjective memory complaints and cognitive impairment in older people. Dement Geriatr Cogn Disord 2006;22:471–85. CrossRef PubMed
- National Institute on Aging. Do memory problems always mean Alzheimer’s disease? Bethesda, MD: National Institutes of Health, National Institute on Aging; 2018. https://www.nia.nih.gov/health/do-memory-problems-always-mean-alzheimers-disease
- CDC. Self-reported increased confusion or memory loss and associated functional difficulties among adults aged ≥60 years—21 states, 2011. MMWR Morb Mortal Wkly Rep 2013;62:347–50. PubMed
- Kaup AR, Nettiksimmons J, LeBlanc ES, Yaffe K. Memory complaints and risk of cognitive impairment after nearly 2 decades among older women. Neurology 2015;85:1852–8. CrossRef PubMed
- Reisberg B, Shulman MB, Torossian C, Leng L, Zhu W. Outcome over seven years of healthy adults with and without subjective cognitive impairment. Alzheimers Dement 2010;6:11–24. CrossRef PubMed
- National Institute on Aging. What is Alzheimer’s disease? Bethesda, MD: National Institutes of Health, National Institute on Aging; 2017. https://www.nia.nih.gov/health/what-alzheimers-disease
- Sharp ES, Gatz M. Relationship between education and dementia: an updated systematic review. Alzheimer Dis Assoc Disord 2011;25:289–304. CrossRef PubMed
- Executive Office of the President of the United States. The long-term decline in prime-age male labor force participation. Washington, DC: Executive Office of the President of the United States; 2016. https://obamawhitehouse.archives.gov/sites/default/files/page/files/20160620_cea_primeage_male_lfp.pdf
- National Institute on Aging. Assessing cognitive impairment in older patients. Bethesda, MD: National Institutes of Health, National Institute on Aging; 2014. https://www.nia.nih.gov/health/assessing-cognitive-impairment-older-patients
Suggested citation for this article: Taylor CA, Bouldin ED, McGuire LC. Subjective Cognitive Decline Among Adults Aged ≥45 Years — United States, 2015–2016. MMWR Morb Mortal Wkly Rep 2018;67:753–757. DOI: http://dx.doi.org/10.15585/mmwr.mm6727a1.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.
All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
Questions or messages regarding errors in formatting should be addressed to firstname.lastname@example.org.
- Page last reviewed: July 12, 2018
- Page last updated: July 12, 2018
- Content source: